CARA - Cara Therapeutics EPS beats by $0.03 misses on revenue February, 27 2020 04:07 PM Cara Therapeutics Inc. Cara Therapeutics (NASDAQ:CARA): Q4 GAAP EPS of -$0.61 beats by $0.03.Revenue of $4.5M (-18.6% Y/Y) misses by $0.89M.Press ReleaseMore news on: Cara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,